Connection

Patrick Woster to Histone Deacetylase Inhibitors

This is a "connection" page, showing publications Patrick Woster has written about Histone Deacetylase Inhibitors.
  1. Use of polyamine derivatives as selective histone deacetylase inhibitors. Methods Mol Biol. 2011; 720:475-91.
    View in: PubMed
    Score: 0.339
  2. Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors. J Med Chem. 2008 Apr 24; 51(8):2447-56.
    View in: PubMed
    Score: 0.280
  3. Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors. J Med Chem. 2005 Oct 06; 48(20):6350-65.
    View in: PubMed
    Score: 0.236
  4. Epigenetics: novel therapeutics targeting epigenetics. J Med Chem. 2015 Jan 22; 58(2):523-4.
    View in: PubMed
    Score: 0.112
  5. Design of polyamine-based therapeutic agents: new targets and new directions. Essays Biochem. 2009 Nov 04; 46:77-94.
    View in: PubMed
    Score: 0.078
  6. Recent advances in the development of polyamine analogues as antitumor agents. J Med Chem. 2009 Aug 13; 52(15):4551-73.
    View in: PubMed
    Score: 0.077
  7. A novel histone deacetylase inhibitor prevents IL-1beta induced metabolic dysfunction in pancreatic beta-cells. J Cell Mol Med. 2009 Aug; 13(8B):1877-85.
    View in: PubMed
    Score: 0.077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.